Live feed16:02:16·156dINSIDERFilingvia QuantisnowChief Financial Officer Adawi Kamal was granted 25,000 shares, increasing direct ownership by 33% to 100,000 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.FATE· Fate Therapeutics Inc.Health CareOriginal source
